Press release
Biostimulants Market Current Trends and Future Prospective
The market for biostimulants is projected to reach USD 4.9 billion by 2025, at a CAGR of 11.24% during the forecast period. It is driven by seaweed extract-based biostimulants, abundant growth in seaweed cultivation near major biostimulant markets, and rise in their adoption by key players in biostimulant formulations.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1081
The seaweeds extracts segment is projected to grow at the highest rate during the forecast period.
Extracts from marine algae, known as seaweed extracts, are marketed to be used in the agriculture industry. Intensive research on biostimulants and plant nutritional products has increased the awareness pertaining to the benefits of seaweed extracts in agriculture. Application of seaweed extracts in agriculture not only reduces the side effects of harmful agrochemicals but also helps in protecting the environment. High marine culture and seaweed production in the Asian countries is projected to drive the seaweed extracts segment in this region, wherein low-value production of seaweed extracts by the Indian and Chinese domestic players can be observed.
The foliar treatment segment is estimated to dominate the biostimulants market in 2019.
Foliar spray application is one of the most widely used methods of using biostimulants, to maximize production efficiency. The direct application on leaves through the foliar application method is considered the most effective way of supplying nutrients to plants, resulting in the rapid absorption and enhancement of micronutrient intake in each part of the shoots and roots. Moreover, the foliar application method is found to be a highly effective way of utilizing biostimulants for fruit & vegetable crops.
Request for Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=1081
With the introduction of stringent regulations, Europe is estimated to dominate the biostimulants market in 2019.
The biostimulants market in Europe is driven by the adoption of modern agricultural technology such as precision farming, plant biotechnology, and organic-based active ingredients. The increasing awareness of consumers about the benefits of biostimulants is expected to contribute to market growth. Moreover, the European legislation is in the process of recognizing biostimulants as important plant nutrition, and have paved the way toward a regulated environment for these products. Moreover, biostimulant products were initially applied only on high-value crops such as fruits and vegetables in Europe. However, the industrial importance has transformed some broad-acre crops such as corn and wheat into high-value crops, resulting in the increased use of biostimulants for these crops.
This report includes a study of the development strategies of leading companies. The scope of this report includes a detailed study of biostimulant manufacturers such as BASF (Germany), Isagro (Italy), Valagro (Italy), Bayer (Germany), Italpollina (Italy), and UPL (India).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biostimulants Market Current Trends and Future Prospective here
News-ID: 2256168 • Views: …
More Releases from Markets and Markets

Controlled-release Fertilizers Market Latest Trends, Demands, Overview and Analy …
The controlled-release fertilizers market is experiencing notable growth, estimated at USD 2.2 billion in 2023 and projected to reach USD 2.9 billion by 2028. This reflects a compound annual growth rate (CAGR) of 5.9% during the forecast period. The demand for controlled-release fertilizers is increasing due to their benefits in enhancing nutrient efficiency, reducing environmental impact, and supporting sustainable agricultural practices.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136099624
These fertilizers are prized for their ability…

Gelatin Market is Projected to Reach $5.6 billion by 2029, at a CAGR of 6.9% fro …
According to a research report titled "Gelatin Market by Source (Animal, Plants), By Applications (Food & Beverages, Pharmaceuticals, Health & Nutrition, Cosmetics, Personal Care, Animal Feed), Type (Type A, Type B), Function (Thickener, Stabilizer, Gelling Agent) - Global Forecast to 2029," published by MarketsandMarkets, the gelatin market is poised for significant growth. The market, valued at USD 4.0 billion in 2024, is projected to reach USD 5.6 billion by 2029,…

Facility Management Market Status, Revenue, Growth Rate, Services and Solutions
According to a research report "Facility Management Market by Offering (Solutions (IWMS, BIM, Facility Operations & Security Management) and Services), Vertical (BFSI, Retail, Construction & Real Estate, Healthcare & Life sciences) and Region - Global Forecast to 2028" published by MarketsandMarkets, the facility management market is estimated at USD 49.6 billion in 2023 to USD 94.8 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 13.8%.
Download PDF Brochure:…

Endpoint Security Market Size, Revenue, Growth Rate Analysis and Forecast 2024
According to a research report "Endpoint Security Market by Solution (Endpoint Protection Platform and Endpoint Detection and Response), Service, Deployment Mode, Organization Size, Vertical (Healthcare, Retail and eCommerce, and Government), and Region - Global Forecast to 2024", published by MarketsandMarkets, the global endpoint security market size is expected to grow from USD 12.8 billion in 2019 to USD 18.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of…
More Releases for MarketsandMarkets™
Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing…
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic…
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing…
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.…
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical…
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are…